|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-12-14
|
|
pubmed:abstractText |
Patients with chronic heart failure (HF) are characterized by alterations in matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) levels. However, the impact of hypolipidemic and antioxidant treatment in MMPs and TIMPs is unknown. In the present study, we sought to compare the effects of statins and xanthine oxidase inhibitors on circulating levels of MMPs and TIMPs in patients with chronic HF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allopurinol,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radical Scavengers,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/MMP2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1874-1754
|
|
pubmed:author |
pubmed-author:AndreouIoannisI,
pubmed-author:AntoniadesCharalambosC,
pubmed-author:CharakidaMariettaM,
pubmed-author:GounariPanagiotaP,
pubmed-author:KotrogiannisIasonI,
pubmed-author:MiliouAntigoniA,
pubmed-author:PapageorgiouNikolaosN,
pubmed-author:StefanadisChristodoulosC,
pubmed-author:TentolourisCostasC,
pubmed-author:TousoulisDimitrisD,
pubmed-author:TrikasAthanasiosA
|
|
pubmed:copyrightInfo |
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
145
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
438-43
|
|
pubmed:meshHeading |
pubmed-meshheading:19539384-Aged,
pubmed-meshheading:19539384-Allopurinol,
pubmed-meshheading:19539384-Biological Markers,
pubmed-meshheading:19539384-Chronic Disease,
pubmed-meshheading:19539384-Drug Therapy, Combination,
pubmed-meshheading:19539384-Extracellular Matrix,
pubmed-meshheading:19539384-Female,
pubmed-meshheading:19539384-Fluorobenzenes,
pubmed-meshheading:19539384-Free Radical Scavengers,
pubmed-meshheading:19539384-Heart Failure,
pubmed-meshheading:19539384-Humans,
pubmed-meshheading:19539384-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19539384-Male,
pubmed-meshheading:19539384-Matrix Metalloproteinase 2,
pubmed-meshheading:19539384-Matrix Metalloproteinase 9,
pubmed-meshheading:19539384-Middle Aged,
pubmed-meshheading:19539384-Pyrimidines,
pubmed-meshheading:19539384-Sulfonamides,
pubmed-meshheading:19539384-Tissue Inhibitor of Metalloproteinase-1,
pubmed-meshheading:19539384-Tissue Inhibitor of Metalloproteinase-2
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
|
|
pubmed:affiliation |
1st Cardiology Department, Athens University Medical School, Hippokration Hospital, Athens, Greece. drtousoulis@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
